Another Negative Sign for Celltrion: Remsima Retail Price Is Falling Too Fast Too Much
Celltrion Healthcare (091990 KS) submitted its 1H18 semi-annual report yesterday. And with this semi-annual report, we finally got to know the...
858 Views
Celltrion (068270): Time Is Not Right for Short Sellers Yet
First, let me tell you this. I'm also a Celltrion basher. I don't like their accounting practices and dual company structure. Not only that,...
502 Views
Celltrion: Manufacturing Risks Remain
Celltrion Inc (068270 KS) continues to struggle with meeting the USFDA's standards for Good Manufacturing Practices. The agency issued a Form 483...
568 Views
Sell Celltrion Inc (068270 KS): Story Unravelling
UPDATE: J&J release Q2 results - 24th July 2018 J&J’s US Remicade sales were flat QoQ. This undermines the story that Celltrion Group is...
609 Views
Updates on Korea's Chaebol Reforms - Proposed Revisions of the Fair Trade Act Were Specified
On 6 July 2018, a public hearing on proposed revisions of the Fair Trade Act was held. In my earlier insight Korean Conglomerates Likely to Embark...
541 Views